Cannergrow | Why Information of the Upcoming Launches are the success Keys
Cannerald could no longer keep it secret:
Next Wednesday the sale of the new location will be initiated. This will also involve a price increase, the background to which I would like to explain in more detail here.
The growth is fast from Cannergrow and they have to cope with an almost unimaginable number of tasks every day:
New hires, production, but also sales efforts are currently increasing in many respects from day to day. In the meantime, Cannerrald has sold so many plants that they have to bring several hundred kilograms of cannabis from his high-tech plant to market every month.
In Switzerland, the stated yields were set very high, as we aimed to sell all cannabis to end customers through our products. In the meantime, this has proven to be no longer feasible, as we have an immense amount of CBD, which cannot be sold exclusively via the B2C market.
For example, we bought the cannabis of the last harvest from our customers – (which is intended for our shop) – for a very good market price. Such high prices are currently not possible via the B2B market, though. For this reason, we have to adjust the targeted sales price of the yields for our upcoming plant according to the production mass.
Distribution is easy for us since we are at the top of the B2B market due to the premium-quality that our cannabis facility offers.
Another adjustment to Cannergrows product is the initial price of a plant:
In Switzerland they have increased in favour of the company and adapted to the GMP regulations with a lot of motivation, effort and high own investments, so that Cannergrow can be at the forefront in the race for the most successful cannabis sales.
These costs were included in the calculation for our next facility, as we also will grow our plants there according to the same GMP-regulations. That way, we can be at the top of the EU market. Besides, there is a very likely future scenario that the EU will only allow cannabis on the market that is produced according to these GMP-regulations.
Should this be the case, Cannerald is optimally prepared for these circumstances to happen and can continue selling any harvest yield without encountering problems.
What is GMP and what is it for Cannergrow?
The GMP license is the highest possible license in the production area. For comparison:
The GMP licence is the highest possible licence in the production sector: normally, only companies such as Bayer or Novartis are GMP-licensed. The license allows us to sell medical cannabis directly to pharmaceutical companies or the government.
There is currently no Swiss cannabis producer with a GMP license (laboratories only), because the process is very difficult and requires many years of experience and a high investment of money. Due to the high requirements of the GMP license they need protocols for every step they take:
For example, we have to explain to the inspector how we clean the walls, racks, floors or how our staff put on their cleanroom clothing in the airlock.
Die gute Nachricht ist:
We will be one of the first cannabis producers in Switzerland, Germany, and Austria with a GMP license! We are planning to obtain this license Q4 2020, as the inspections will be carried out by a government agency. There is no fixed date, so this will take some time.
We can be curious to see how Cannerald – Cannergrow develops further.
- Juicy Fields | Product catalog on the market was now published - 25. November 2020
- Cannerald | FAQ and important CannerGrow information – November 2020 - 22. November 2020
- BioMindX Reviews – Earn money with BioMindx CBG cannabis market and CBD Mat - 21. November 2020